Skip to main content
OCUMETICS TECHNOLOGY CORP. logo

OCUMETICS TECHNOLOGY CORP. — Investor Relations & Filings

Ticker · OTC LEI · 254900774FCFVTN0GE02 TSXV Manufacturing
Open in API
Filings indexed 175 across all filing types
Latest filing 2025-07-17 Capital/Financing Update
Country CA Canada
Listing TSXV OTC

About OCUMETICS TECHNOLOGY CORP.

https://ocumetics.com/

Ocumetics Technology Corp. is a research and product development company specializing in advanced refractive technologies for the ophthalmic industry. The company's core focus is the development of the Ocumetics Accommodating Lens, a proprietary intraocular lens (IOL) designed to restore natural visual accommodation. This lens aims to provide clear distance and near vision without the need for corrective eyeglasses or perceptible focus lag, addressing age-related vision deterioration such as presbyopia. The patented design utilizes the eye's natural ciliary muscle kinetics to efficiently link nerve impulses with curvature change. Furthermore, the lens framework is engineered to serve secondarily as a docking station for customized optics and evolving nanotechnologies.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Capital/Financing Update Classification · 1% confidence The document is a press release announcing the completion of the first tranche of a private placement, detailing the number of units issued, warrants, proceeds raised, use of proceeds, related party participation, and hold periods. This is a financing activity update. There is no mention of dividend, share issue broad notifications beyond private placement, or full financial results. Therefore, it classifies as a Capital/Financing Update.
2025-07-17 English
News release - English.pdf
Capital/Financing Update Classification · 1% confidence The document is a press release announcing the completion of the first tranche of a private placement (a financing transaction), detailing units issued, warrants, agent fees, and use of proceeds. This is a company fundraising update, so it falls under the Capital/Financing Update category.
2025-07-17 English
News release - English.pdf
Regulatory Filings Classification · 1% confidence The document is a corporate news release announcing clinical staff training completion for a first-in-human study. It is not an earnings announcement (no financial results), not a formal periodic report, not a management or investor presentation, nor a regulatory report attachment. It does not fit specialized categories like M&A, dividend, board changes, or share transactions. Therefore it falls into the general ‘Regulatory Filings’ fallback category (RNS).
2025-07-09 English
News release - English.pdf
Regulatory Filings Classification · 1% confidence The document is a company news release (“NEWS RELEASE”) announcing the submission of a clinical study protocol for IRB approval and planned site initiation. It does not present quarterly or annual financial results (so not ER/IR/10-K), is not reporting insider trades, board changes, dividends, financing, M&A, or any regulatory interest-rate or capital changes. It is a generic operational update/press release without a specific dedicated category, so it falls into the fallback “Regulatory Filings” category (RNS).
2025-05-22 English
News release - English.pdf
Regulatory Filings Classification · 1% confidence The document is a corporate news release announcing a product development milestone (“Lens Design Freeze for First-in-Human Study”). It does not present financial results, management changes, voting results, or any specific regulatory filing/form. It is a general announcement/press release that does not fit any specialized category, so it falls under the fallback Regulatory Filings category (RNS).
2025-05-12 English
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings Classification · 1% confidence The document is a Form 52-109F2 “Venture Issuer Basic Certificate” – a regulatory certificate by the CFO certifying the company’s interim filings (interim financial report and MD&A) under Canadian NI 52-109. It is not the interim report itself (IR) nor an announcement of publication (RPA), but rather a required compliance filing that does not fit a more specific category. Therefore it should be classified as a general regulatory filing (RNS).
2025-05-09 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.